WHIPPANY, N.J., September 29, 2026--Bayer today announced the launch of MiraSOFT, a new stool softener option from the makers of MiraLAX® with the active ingredient docusate sodium designed to help gently soften hard, dry stools and support more comfortable, easier bowel movements. * MiraSOFT is now available at over 7,000 CVS Pharmacy locations and at cvs.com.
The latest trading day saw CVS Health (CVS) settling at $87.85, representing a -1.44% change from its previous close.
Why CVS Health Stock Is Back On Traders’ Screens CVS Health (CVS) has jumped back into focus after a 4.8% move on September 25 pushed the share price to $89.13 and back above its 200 day EMA. That single session pulled the stock higher even as the broader daily trend still points lower. This has given short term traders fresh technical signals, while longer term investors are assessing whether this latest bounce changes the story. Set against that sudden spike, CVS Health has had a mixed run,...
CVS Group PLC (CVSGF) posted solid full-year revenue and EBITDA growth, expanded in Australia, and signaled confidence in returning to its 4%--8% like-for-like range despite softer consumer footfall.
NORTHAMPTON, MA / ACCESS Newswire / September 25, 2026 / Originally published on Company NewsroomThe demand for reliable energy continues to grow, and for , dependable operations are essential to serving millions of patients and customers across the country. That's why we're expanding our use of renewable electricity and investing in energy solutions that help reduce emissions, strengthen business resilience and support uninterrupted care.
If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The company also announced its first acquisition in the UK days after the conclusion of the Competition and Markets Authority probe.
CVS Group (LSE:CVSG) reported a 5. 9% increase in full-year revenue to £712.
CVS Group (LON:CVSG) reported full-year revenue growth of 5.9% to £712.8 million and adjusted EBITDA growth of 5.1% to £141.5 million, as all three divisions contributed to growth despite softer market conditions late in the year. Chief Executive Officer Richard Fairman said the company delivered r
CVS has agreed to a settlement in a class action lawsuit that will give customers money. Here's who's eligible.
Four winning designs will be featured on limited-edition CVS brand bandages for sale in 2027Originally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 23, 2026 / ® (NYSE:CVS) recently announced the launch of its nationwide "Wear Your HeART" Bandage Art Contest, inviting people across the United States to submit original artwork inspired by the importance of protecting personal, family and community health.The contest offers artists, students, families and community grou
Polaris Capital Management, an investment management company, released its second-quarter 2026 investor letter for “Global Equity Strategy”. The letter can be downloaded here. Global markets delivered strong gains during the quarter, supported by an AI-driven earnings rally despite elevated interest rates, inflation concerns, and geopolitical uncertainty. Polaris Global Equity Composite (net of fees) returned 13.26% […]
Analysts review high-yield healthcare stocks CVS, Viatris and Medtronic, citing ratings, price targets, dividend yields and recent company news.
Key Stats for CVS Health StockCurrent Price: $88. 84Target Price (Mid): ~$130Street Target: ~$116Potential Total Return: ~47%Annualized IRR: ~9% / yearWhat Happened?CVS Health (CVS) slid to a $88.
CVS Health (CVS) concluded the recent trading session at $87.6, signifying a -1.4% move from its prior day's close.
Detailed price information for CVS Corp (CVS-N) from The Globe and Mail including charting and trades.
CVS, Steris and Baxter are oversold healthcare stocks with RSI readings near or below 30, potentially offering undervalued buying opportunities.
Doses of Moderna’s mFlusiva are available at CVS. Walgreens expects to begin receiving shipments of the vaccine any day now.
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with CVS Health (NYSE:CVS).
Originally published on Company NewsroomThe new mini-pitch brings safe access to play to Orchards Elementary School in Vancouver, WA, as part of 's multi-year field revitalization commitmentNORTHAMPTON, MA AND WOONSOCKET, RI / ACCESS Newswire / September 18, 2026 / ® (NYSE:CVS) announced it has redeveloped a mini soccer pitch in collaboration with Seattle Reign FC and the club's charitable arm, the RAVE Foundation. The mini-pitch, which is located at Orchards Elementary in Vancouver, WA, is now
CVS Health (CVS) unit Aetna launches a single prior authorization for cancer care, cutting admin burden and care delays.Read more here.
CVS trades at a forward multiple that screams cheap, yet the street's already bullish and our model runs even hotter. Before you trust either read, there are a few risks that could turn this setup into a trap.
CVS Health® today announced the launch of its nationwide "Wear Your HeART" Bandage Art Contest, inviting people across the United States to submit original artwork inspired by the importance of protecting personal, family and community health.
CVS Health (NYSE:CVS) announced the rollout of updated 2026 to 2027 COVID-19 vaccines across CVS Pharmacy and MinuteClinic locations. The new vaccines are positioned for broad availability through CVS Health’s nationwide network of retail pharmacies and in store clinics. CVS Health highlighted the vaccines as part of its role in supporting ongoing COVID-19 management and wider public health efforts. This fresh 2026 to 2027 COVID-19 vaccine rollout at CVS Health sits against a wider backdrop...
Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.